LIPOSOMALALLIANCE
Cross-section of a liposome showing its lipid bilayer

Science · Standards · Collaboration

Advancing the Science.
Strengthening the Standards.

An emerging independent initiative connecting researchers, analytical specialists, pharmaceutical scientists, manufacturers, and industry professionals to advance rigorous science and responsible innovation in liposomal technology.

Why the Alliance

Building a Stronger Foundation for Liposomal Technology.

As liposomal applications expand across pharmaceutical and nutraceutical fields, scientific clarity, analytical consistency, manufacturing integrity, and transparent communication become increasingly important. Liposomal Alliance is being developed as a collaborative platform for experts committed to strengthening these foundations.

Four Pillars

The principles guiding our work.

I

Scientific Verification

Encouraging rigorous characterization including electron microscopy, particle size distribution, PDI, zeta potential, encapsulation efficiency, lipid bilayer assessment, stability, and appropriately designed biological and clinical studies.

II

Manufacturing & Supply Chain Integrity

Promoting quality systems, traceability, process consistency, appropriate GMP practices, and defensible formulation claims.

III

Regulatory Engagement

Supporting scientifically informed dialogue and understanding of relevant regulatory frameworks without claiming regulatory authority.

IV

Consumer & Industry Transparency

Advancing clear terminology, responsible communication, and evidence-led approaches to evaluating liposomal technologies.

Scientific Scope

Three fields. Distinct expectations.

Each area carries its own evidence requirements and regulatory context. The initiative treats them as related but separate disciplines, and does not equate one with another.

01

Nutraceutical Liposomal Delivery

Liposomal and lipid-based formats for dietary ingredients, where characterization, stability and honest communication of delivery claims are central concerns.

Evaluated within food and dietary supplement frameworks.

02

Pharmaceutical Liposomes

Established and investigational liposomal drug products, developed under pharmaceutical quality systems with rigorous clinical and analytical evidence.

Subject to medicinal product regulation and clinical evidence standards.

03

Lipid Nanoparticles & Emerging Technologies

Lipid nanoparticles and novel lipid-based carriers, an active field of research with evolving analytical methods and terminology.

Expectations depend on application, intended use and jurisdiction.

Founding Initiative

Help Shape the Future of Liposomal Science.

Liposomal Alliance is currently in its founding development phase. We welcome expressions of interest from scientists, academic researchers, analytical laboratories, pharmaceutical specialists, ingredient developers, manufacturers, and brand R&D professionals who share a commitment to scientific integrity.

Express Interest

Insights

Perspectives & Scientific Dialogue.

In Development

Articles

Accessible commentary on characterization, terminology and quality topics.

In Development

Position Papers

Considered perspectives developed collaboratively with contributors.

In Development

Technical Discussions

Focused examinations of analytical methods and manufacturing practice.

In Development

Scientific Roundtables

Moderated dialogue across research, industry and analytical disciplines.

No content has been published yet. This area will open as contributions are developed.